3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow COLD-fX: new trials by email Literature Review of COLD-fX trials Research Report on COLD-fX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population North American ginseng, Placebo - Upper Respiratory Tract Infections | Phase 2 | Completed | Afexa Life Sciences Inc | 293 | 2009-09-01 | 2012-08-31 |
| A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis COLD-fX, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Afexa Life Sciences Inc | 200 | 2008-05-01 | 2010-10-11 |
| Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults CVT E002 (Cold-fX) - Healthy | Phase 2 | Completed | CV Technologies | 50 | 2007-03-01 | 2007-07-17 |
Hypersensitivity (1) · Pruritus (1) · Respiratory Tract Infections (1) · Rhinitis, Allergic, Seasonal (1) · Sneezing (1)
Afexa Life Sciences Inc (2) · CV Technologies (1)
Canada (2) · United States (1)
Gerald Predy, FFCPC (1) · Shelly McNeil, FRCPC (1) · Steven Sperber, MD (1)